$2.45 - NRXP | NRX Pharmaceuticals, Inc. Common Stock

NRX Pharmaceuticals, Inc. Common Stock (NRXP)

NRX Pharmaceuticals, Inc. Common Stock

XNAS:NRXP

2.45

4.70%

Ask

$10.00 - 4,937.00

Bid

$2.40 - 468.00

Low

$2.36

High

$2.51

Open

$2.5

Prev Close

$2.34

52W High

6.01

52W Low

1.15

Volume

142933

Avg Vol (3m)

436739.9

Float

24851596.66

Chart

TendieTensor AI Analysis

Company

Asset Type: Common Stock

SIC Code: 2834

Sector: Health Technology

Industry: Pharmaceuticals: Major

Date Listed: 05/25/2021

Primary Exchange: XNAS

NRX Pharmaceuticals Inc is a clinical-stage, small-molecule pharmaceutical company that develops and plans to distribute novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. It has announced the commercialization of ZYESAMI (Aviptadil), an application for COVID-related respiratory failure. The company is also developing NRX-100/101, the first sequential drug regimen for bipolar depression in patients with acute suicidal ideation and behavior.

Phone: 484-254-6134

Address: 1201 Orange Street

Address 2: Suite 600

City: Wilmington

State: DE

Postal Code: 19801

Website

TendieTensor AI Analyst Recommendation: —

Fundamentals

P/E (TTM)

-1.040000

P/B (TTM)

-2.633400

EPS

-0.5

Round Lot

100

Composit FIGI

BBG00JCWDN63

Share Class FIGI

BBG00JCWDNX3

Share Class Shares Outstanding

19.81M

Weighted Shares Outstanding

23.77M

Technicals

RSI (14)

MACD Line

MACD Signal

SMA 20

SMA 50

EMA 50

Trend

Short Interest

—

Days to Cover

— —

Higher = harder to cover

Short Interest Δ

—

Prev: —

Short Volume Ratio (Today)

— —

5D avg: —

Squeeze Score (0–100)

—

Discussion